Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 608512, 10 pages
http://dx.doi.org/10.1155/2014/608512
Research Article

Effect of the Antihypertensive Drug Enalapril on Oxidative Stress Markers and Antioxidant Enzymes in Kidney of Spontaneously Hypertensive Rat

1Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia
2Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia

Received 12 February 2014; Revised 14 July 2014; Accepted 14 July 2014; Published 28 August 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 G. Chandran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. “World Health Statistics 2012,” World Health Organization (WHO) Report, http://www.who.int/gho/publications/world_health_statistics/2012/en.
  3. J. D. Swales, Textbook of Hypertension, Blackwell Scientific Publishers, Boston, Mass, USA, 1994.
  4. R. M. Touyz, “Oxidative stress and vascular damage in hypertension.,” Current hypertension reports, vol. 2, no. 1, pp. 98–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. C. S. Wilcox, “Reactive oxygen species: roles in blood pressure and kidney function,” Current Hypertension Reports, vol. 4, no. 2, pp. 160–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. McCord, “Human disease, free radicals, and the oxidant/antioxidant balance,” Clinical Biochemistry, vol. 26, no. 5, pp. 351–357, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lunec, “Free radicals: Their involvement in disease processes,” Annals of Clinical Biochemistry, vol. 27, no. 3, pp. 173–182, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Halliwell, J. M. C. Gutteridge, and C. E. Cross, “Free radicals, antioxidants, and human disease: where are we now?” Journal of Laboratory and Clinical Medicine, vol. 119, no. 6, pp. 598–620, 1992. View at Google Scholar · View at Scopus
  9. R. D. Manning Jr., N. Tian, and S. Meng, “Oxidative stress and antioxidant treatment in hypertension and the associated renal damage,” The American Journal of Nephrology, vol. 25, no. 4, pp. 311–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Y. Tse, S. R. J. Maxwell, H. Thomason et al., “Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage,” Journal of Human Hypertension, vol. 8, no. 11, pp. 843–849, 1994. View at Google Scholar · View at Scopus
  11. C. Russo, O. Olivieri, D. Girelli et al., “Anti-oxidant status and lipid peroxidation in patients with essential hypertension,” Journal of Hypertension, vol. 16, no. 9, pp. 1267–1271, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Minuz, P. Patrignani, S. Gaino et al., “Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease,” Circulation, vol. 106, no. 22, pp. 2800–2805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Lacy, M. T. Kailasam, D. T. O'Connor, G. W. Schmid-Schönbein, and R. J. Parmer, “Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity,” Hypertension, vol. 36, no. 5, pp. 878–884, 2000. View at Google Scholar · View at Scopus
  14. G. D. Laverman, G. Remuzzi, and P. Ruggenenti, “Ace inhibition versus angiotensin receptor blockade : which is better for renal and cardiovascular protection,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. S64–S70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Berl, “Angiotensin-converting enzyme inhibitors versus AT1 antagonist in cardiovascular and renal protection : the case for AT1 receptor antagonist,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. S71–S76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. L. M. M. Pereira, J. R. Almeida, and C. A. Mandarim-de-Lacerda, “Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats,” Life Sciences, vol. 74, no. 11, pp. 1375–1386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Boffa, Y. Lu, S. Placier, A. Stefanski, J. Dussaule, and C. Chatziantoniou, “Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1132–1144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Tong Mak, P. Boehme, and W. B. Weglicki, “Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells: correlation of protection with preservation of glutathione levels,” Circulation Research, vol. 70, no. 6, pp. 1099–1103, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Wiemer, W. Linz, S. Hatrik, B. A. Schölkens, and T. Malinski, “Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats,” Hypertension, vol. 30, no. 5, pp. 1183–1190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Rajagopalan, S. Kurz, T. Munzel et al., “Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone,” Journal of Clinical Investigation, vol. 97, no. 8, pp. 1916–1923, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Bayorh, A. A. Ganafa, R. R. Socci, D. Eatman, N. Silvestrov, and I. K. Abukhalaf, “Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats,” American Journal of Hypertension, vol. 16, pp. 387–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Mantle, V. B. Patel, H. J. F. Why et al., “Effects of lisinopril and amlodipine on antioxidant status in experimental hypertension,” Clinica Chimica Acta, vol. 299, no. 1-2, pp. 1–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Zhou and E. D. Frohlich, “Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR,” Medicinal Chemistry, vol. 3, no. 1, pp. 61–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Baylis, B. Mitruka, and A. Deng, “Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage,” The Journal of Clinical Investigation, vol. 90, no. 1, pp. 278–281, 1992. View at Google Scholar · View at Scopus
  25. J. Wessels, P. Peake, B. A. Pussell, and G. J. Macdonald, “Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathy,” Clinical and Experimental Pharmacology and Physiology, vol. 24, no. 6, pp. 451–453, 1997. View at Google Scholar · View at Scopus
  26. M. Gerová, “Nitric oxide-compromised hypertension: facts and enigmas,” Physiological Research, vol. 49, no. 1, pp. 27–35, 2000. View at Google Scholar · View at Scopus
  27. R. B. Scott, K. S. Reddy, K. Husain, E. C. Schlorff, L. P. Rybak, and S. M. Somani, “Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat,” Pathophysiology, vol. 7, no. 1, pp. 25–32, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Watanabe, S. Kamei, A. Ohkubo et al., “Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer,” Clinical Chemistry, vol. 32, no. 8, pp. 1551–1554, 1986. View at Google Scholar · View at Scopus
  29. D. Koracevic, G. Koracevic, V. Djordjevic, S. Andrejevic, and V. Cosic, “Method for the measurement of antioxidant activity in human fluids,” Journal of Clinical Pathology, vol. 54, no. 5, pp. 356–361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. P. K. Chatterjee, S. Cuzzocrea, P. A. J. Brown et al., “Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat,” Kidney International, vol. 58, no. 2, pp. 658–673, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Dogan, G. Tanrikulu, U. Soyuer, and K. Kose, “Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behcet's disease,” Clinical Biochemistry, vol. 27, no. 5, pp. 413–418, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Goth, “A simple method for determination of serum catalase activity and revision of reference range,” Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143–151, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. M. Pinto, M. Paul, and D. Ganten, “Lessons from rat models of hypertension: from Goldblatt to genetic engineering,” Cardiovascular Research, vol. 39, no. 1, pp. 77–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Chandran, K. N. S. Sirajudeen, C. W. Tee, and H. A. Nadiger, “Time course study on oxidative stress in kidney of spontaneously hypertensive rat,” The Malaysian Journal of Medical Sciences, vol. 12, supplement 1, p. 201, 2005. View at Google Scholar
  35. C. Rugale, M. Cordaillat, A. Mimran, and B. Jover, “Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 6, no. 3, pp. 154–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. A. W. Dukacz, M. Feng, L. Yang, R. M. K. W. Lee, and R. L. Kline, “Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment,” American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 280, no. 4, pp. R1076–R1084, 2001. View at Google Scholar · View at Scopus
  37. C. K. Fujihara, D. M. A. C. Malheiros, I. D. L. Noronha, G. de Nucci, and R. Zatz, “Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model,” Hypertension, vol. 37, no. 1, pp. 170–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. J. G. Dickhout and R. M. Lee, “Blood pressure and heart rate development in young spontaneously hypertensive rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 274, no. 3, pp. H794–H800, 1998. View at Google Scholar · View at Scopus
  39. S. K. Lee, S. Arunkumar, K. N. S. Sirajudeen, and H. J. Singh, “Glutathione system in young spontaneously hypertensive rats,” Journal of Physiology and Biochemistry, vol. 66, no. 4, pp. 321–327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. O. Oyekan, K. Mcaward, J. Conetta, L. Rosenfeld, and J. C. Mcgiff, “Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 276, no. 3, pp. R766–R775, 1999. View at Google Scholar · View at Scopus
  41. J. Laakso, E. Mervaala, J. Himberg et al., “Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension,” Hypertension, vol. 32, no. 5, pp. 902–906, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. D. V. Nosratola, “Causal link between oxidative stress, inflammation and hypertension,” Iranian Journal of Kidney Diseases, vol. 2, pp. 1–10, 2008. View at Google Scholar
  43. H. D. Khanna, M. K. Sinha, S. Khanna, and R. Tandon, “Oxidative stress in hypertension: association with antihypertensive treatment,” Indian Journal of Physiology and Pharmacology, vol. 52, no. 3, pp. 283–287, 2008. View at Google Scholar · View at Scopus
  44. N. Tian, K. D. Thrasher, P. D. Gundy, M. D. Hughson, and R. D. Manning Jr., “Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension,” Hypertension, vol. 45, no. 5, pp. 934–939, 2005. View at Publisher · View at Google Scholar · View at Scopus